Reuters logo
5 个月前
BRIEF-Allergan and Paratek announce positive results from two phase 3 trials
2017年3月27日 / 中午11点41分 / 5 个月前

BRIEF-Allergan and Paratek announce positive results from two phase 3 trials

March 27 (Reuters) - Paratek Pharmaceuticals Inc:

* Allergan and Paratek announce positive results from two phase 3 trials of sarecycline for the treatment of moderate to severe acne

* Paratek Pharmaceuticals - two phase 3 trials of sarecycline for treatment of moderate to severe acne met their 12 week primary efficacy endpoints

* Paratek Pharmaceuticals says Allergan plans to file a new drug application (NDA) to U.S. Food & Drug Administration (FDA) in second half of this year Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below